 | • レポートコード：D0804-15526 • 出版社/出版日：GlobalInfoResearch / 2020年7月28日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、124ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、循環腫瘍細胞の世界市場を広く調査・分析し、今後の市場展望をまとめております。循環腫瘍細胞の種類別市場規模（CTC濃縮、CTC検出、CTC分析）、用途別市場規模（乳がん、前立腺がん、大腸がん、肺がん、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Menarini-Silicon Biosystems、SurExamBio-Tech、ApoCell、Qiagen (Adnagen)、Cynvenio、Advanced Cell Diagnostics、Ikonisys、Greiner Bio-one GmbH、Epic Sciences、Fluxion Biosciences、Celsee、Hangzhou Watson Biotech、Clearbridge Biomedics、Guangzhou Wondfo Biotech、Biocept、ANGLE plc、CytoTrack ・地域別グローバル市場分析 2015年-2020年 ・循環腫瘍細胞の北米市場（アメリカ、カナダ、メキシコ） ・循環腫瘍細胞のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・循環腫瘍細胞のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・循環腫瘍細胞の南米市場（ブラジル、アルゼンチン） ・循環腫瘍細胞の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：CTC濃縮、CTC検出、CTC分析 ・用途別分析：乳がん、前立腺がん、大腸がん、肺がん、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Circulating Tumor Cells market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Circulating Tumor Cells sales will be xx in 2020 from Circulating Tumor Cells million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Circulating Tumor Cells market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Circulating Tumor Cells industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Circulating Tumor Cells and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Circulating Tumor Cells market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Circulating Tumor Cells market has been segmented into:
CTC Enrichment
CTC Detection
CTC Analysis
By Application, Circulating Tumor Cells has been segmented into:
Breast Cancer
Prostate Cancer
Colorectal Cancer
Lung Cancer
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Circulating Tumor Cells market presented in the report. This section sheds light on the sales growth of different regional and country-level Circulating Tumor Cells markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Circulating Tumor Cells market.
The report offers in-depth assessment of the growth and other aspects of the Circulating Tumor Cells market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Circulating Tumor Cells Market Share Analysis
Circulating Tumor Cells competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Circulating Tumor Cells sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Circulating Tumor Cells sales, revenue and market share for each player covered in this report.
The major players covered in Circulating Tumor Cells are:
Menarini-Silicon Biosystems
SurExamBio-Tech
ApoCell
Qiagen (Adnagen)
Cynvenio
Advanced Cell Diagnostics
Ikonisys
Greiner Bio-one GmbH
Epic Sciences
Fluxion Biosciences
Celsee
Hangzhou Watson Biotech
Clearbridge Biomedics
Guangzhou Wondfo Biotech
Biocept
ANGLE plc
CytoTrack
1 Circulating Tumor Cells Market Overview
1.1 Product Overview and Scope of Circulating Tumor Cells
1.2 Classification of Circulating Tumor Cells by Type
1.2.1 Global Circulating Tumor Cells Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Circulating Tumor Cells Revenue Market Share by Type in 2019
1.2.3 CTC Enrichment
1.2.4 CTC Detection
1.2.5 CTC Analysis
1.3 Global Circulating Tumor Cells Market by Application
1.3.1 Overview: Global Circulating Tumor Cells Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Breast Cancer
1.3.3 Prostate Cancer
1.3.4 Colorectal Cancer
1.3.5 Lung Cancer
1.3.6 Other
1.4 Global Circulating Tumor Cells Market by Regions
1.4.1 Global Circulating Tumor Cells Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Circulating Tumor Cells (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Circulating Tumor Cells Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Circulating Tumor Cells Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Circulating Tumor Cells Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Circulating Tumor Cells Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Circulating Tumor Cells Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Circulating Tumor Cells Industry Impact
1.5.1 COVID-19 Potential Implications for the Circulating Tumor Cells
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Circulating Tumor Cells
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Menarini-Silicon Biosystems
2.1.1 Menarini-Silicon Biosystems Details
2.1.2 Menarini-Silicon Biosystems Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Menarini-Silicon Biosystems SWOT Analysis
2.1.4 Menarini-Silicon Biosystems Product and Services
2.1.5 Menarini-Silicon Biosystems Circulating Tumor Cells Revenue, Gross Margin and Market Share (2018-2019)
2.2 SurExamBio-Tech
2.2.1 SurExamBio-Tech Details
2.2.2 SurExamBio-Tech Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 SurExamBio-Tech SWOT Analysis
2.2.4 SurExamBio-Tech Product and Services
2.2.5 SurExamBio-Tech Circulating Tumor Cells Revenue, Gross Margin and Market Share (2018-2019)
2.3 ApoCell
2.3.1 ApoCell Details
2.3.2 ApoCell Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 ApoCell SWOT Analysis
2.3.4 ApoCell Product and Services
2.3.5 ApoCell Circulating Tumor Cells Revenue, Gross Margin and Market Share (2018-2019)
2.4 Qiagen (Adnagen)
2.4.1 Qiagen (Adnagen) Details
2.4.2 Qiagen (Adnagen) Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Qiagen (Adnagen) SWOT Analysis
2.4.4 Qiagen (Adnagen) Product and Services
2.4.5 Qiagen (Adnagen) Circulating Tumor Cells Revenue, Gross Margin and Market Share (2018-2019)
2.5 Cynvenio
2.5.1 Cynvenio Details
2.5.2 Cynvenio Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Cynvenio SWOT Analysis
2.5.4 Cynvenio Product and Services
2.5.5 Cynvenio Circulating Tumor Cells Revenue, Gross Margin and Market Share (2018-2019)
2.6 Advanced Cell Diagnostics
2.6.1 Advanced Cell Diagnostics Details
2.6.2 Advanced Cell Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Advanced Cell Diagnostics SWOT Analysis
2.6.4 Advanced Cell Diagnostics Product and Services
2.6.5 Advanced Cell Diagnostics Circulating Tumor Cells Revenue, Gross Margin and Market Share (2018-2019)
2.7 Ikonisys
2.7.1 Ikonisys Details
2.7.2 Ikonisys Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Ikonisys SWOT Analysis
2.7.4 Ikonisys Product and Services
2.7.5 Ikonisys Circulating Tumor Cells Revenue, Gross Margin and Market Share (2018-2019)
2.8 Greiner Bio-one GmbH
2.8.1 Greiner Bio-one GmbH Details
2.8.2 Greiner Bio-one GmbH Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Greiner Bio-one GmbH SWOT Analysis
2.8.4 Greiner Bio-one GmbH Product and Services
2.8.5 Greiner Bio-one GmbH Circulating Tumor Cells Revenue, Gross Margin and Market Share (2018-2019)
2.9 Epic Sciences
2.9.1 Epic Sciences Details
2.9.2 Epic Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Epic Sciences SWOT Analysis
2.9.4 Epic Sciences Product and Services
2.9.5 Epic Sciences Circulating Tumor Cells Revenue, Gross Margin and Market Share (2018-2019)
2.10 Fluxion Biosciences
2.10.1 Fluxion Biosciences Details
2.10.2 Fluxion Biosciences Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Fluxion Biosciences SWOT Analysis
2.10.4 Fluxion Biosciences Product and Services
2.10.5 Fluxion Biosciences Circulating Tumor Cells Revenue, Gross Margin and Market Share (2018-2019)
2.11 Celsee
2.11.1 Celsee Details
2.11.2 Celsee Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Celsee SWOT Analysis
2.11.4 Celsee Product and Services
2.11.5 Celsee Circulating Tumor Cells Revenue, Gross Margin and Market Share (2018-2019)
2.12 Hangzhou Watson Biotech
2.12.1 Hangzhou Watson Biotech Details
2.12.2 Hangzhou Watson Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Hangzhou Watson Biotech SWOT Analysis
2.12.4 Hangzhou Watson Biotech Product and Services
2.12.5 Hangzhou Watson Biotech Circulating Tumor Cells Revenue, Gross Margin and Market Share (2018-2019)
2.13 Clearbridge Biomedics
2.13.1 Clearbridge Biomedics Details
2.13.2 Clearbridge Biomedics Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Clearbridge Biomedics SWOT Analysis
2.13.4 Clearbridge Biomedics Product and Services
2.13.5 Clearbridge Biomedics Circulating Tumor Cells Revenue, Gross Margin and Market Share (2018-2019)
2.14 Guangzhou Wondfo Biotech
2.14.1 Guangzhou Wondfo Biotech Details
2.14.2 Guangzhou Wondfo Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Guangzhou Wondfo Biotech SWOT Analysis
2.14.4 Guangzhou Wondfo Biotech Product and Services
2.14.5 Guangzhou Wondfo Biotech Circulating Tumor Cells Revenue, Gross Margin and Market Share (2018-2019)
2.15 Biocept
2.15.1 Biocept Details
2.15.2 Biocept Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Biocept SWOT Analysis
2.15.4 Biocept Product and Services
2.15.5 Biocept Circulating Tumor Cells Revenue, Gross Margin and Market Share (2018-2019)
2.16 ANGLE plc
2.16.1 ANGLE plc Details
2.16.2 ANGLE plc Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 ANGLE plc SWOT Analysis
2.16.4 ANGLE plc Product and Services
2.16.5 ANGLE plc Circulating Tumor Cells Revenue, Gross Margin and Market Share (2018-2019)
2.17 CytoTrack
2.17.1 CytoTrack Details
2.17.2 CytoTrack Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 CytoTrack SWOT Analysis
2.17.4 CytoTrack Product and Services
2.17.5 CytoTrack Circulating Tumor Cells Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Circulating Tumor Cells Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Circulating Tumor Cells Players Market Share
3.2.2 Top 10 Circulating Tumor Cells Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Circulating Tumor Cells Revenue and Market Share by Regions
4.2 North America Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
4.3 Europe Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
4.5 South America Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
5 North America Circulating Tumor Cells Revenue by Countries
5.1 North America Circulating Tumor Cells Revenue by Countries (2015-2020)
5.2 USA Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
5.3 Canada Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
5.4 Mexico Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
6 Europe Circulating Tumor Cells Revenue by Countries
6.1 Europe Circulating Tumor Cells Revenue by Countries (2015-2020)
6.2 Germany Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
6.3 UK Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
6.4 France Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
6.5 Russia Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
6.6 Italy Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Circulating Tumor Cells Revenue by Countries
7.1 Asia-Pacific Circulating Tumor Cells Revenue by Countries (2015-2020)
7.2 China Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
7.3 Japan Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
7.4 Korea Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
7.5 India Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
8 South America Circulating Tumor Cells Revenue by Countries
8.1 South America Circulating Tumor Cells Revenue by Countries (2015-2020)
8.2 Brazil Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
8.3 Argentina Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Circulating Tumor Cells by Countries
9.1 Middle East & Africa Circulating Tumor Cells Revenue by Countries (2015-2020)
9.2 Saudi Arabia Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
9.3 UAE Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
9.4 Egypt Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
9.5 South Africa Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Circulating Tumor Cells Revenue and Market Share by Type (2015-2020)
10.2 Global Circulating Tumor Cells Market Forecast by Type (2019-2024)
10.3 CTC Enrichment Revenue Growth Rate (2015-2025)
10.4 CTC Detection Revenue Growth Rate (2015-2025)
10.5 CTC Analysis Revenue Growth Rate (2015-2025)
11 Global Circulating Tumor Cells Market Segment by Application
11.1 Global Circulating Tumor Cells Revenue Market Share by Application (2015-2020)
11.2 Circulating Tumor Cells Market Forecast by Application (2019-2024)
11.3 Breast Cancer Revenue Growth (2015-2020)
11.4 Prostate Cancer Revenue Growth (2015-2020)
11.5 Colorectal Cancer Revenue Growth (2015-2020)
11.6 Lung Cancer Revenue Growth (2015-2020)
11.7 Other Revenue Growth (2015-2020)
12 Global Circulating Tumor Cells Market Size Forecast (2021-2025)
12.1 Global Circulating Tumor Cells Market Size Forecast (2021-2025)
12.2 Global Circulating Tumor Cells Market Forecast by Regions (2021-2025)
12.3 North America Circulating Tumor Cells Revenue Market Forecast (2021-2025)
12.4 Europe Circulating Tumor Cells Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Circulating Tumor Cells Revenue Market Forecast (2021-2025)
12.6 South America Circulating Tumor Cells Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Circulating Tumor Cells Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Circulating Tumor Cells Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Circulating Tumor Cells by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Circulating Tumor Cells Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Circulating Tumor Cells Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Circulating Tumor Cells Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Menarini-Silicon Biosystems Corporate Information, Location and Competitors
Table 7. Menarini-Silicon Biosystems Circulating Tumor Cells Major Business
Table 8. Menarini-Silicon Biosystems Circulating Tumor Cells Total Revenue (USD Million) (2017-2018)
Table 9. Menarini-Silicon Biosystems SWOT Analysis
Table 10. Menarini-Silicon Biosystems Circulating Tumor Cells Product and Solutions
Table 11. Menarini-Silicon Biosystems Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. SurExamBio-Tech Corporate Information, Location and Competitors
Table 13. SurExamBio-Tech Circulating Tumor Cells Major Business
Table 14. SurExamBio-Tech Circulating Tumor Cells Total Revenue (USD Million) (2018-2019)
Table 15. SurExamBio-Tech SWOT Analysis
Table 16. SurExamBio-Tech Circulating Tumor Cells Product and Solutions
Table 17. SurExamBio-Tech Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. ApoCell Corporate Information, Location and Competitors
Table 19. ApoCell Circulating Tumor Cells Major Business
Table 20. ApoCell Circulating Tumor Cells Total Revenue (USD Million) (2017-2018)
Table 21. ApoCell SWOT Analysis
Table 22. ApoCell Circulating Tumor Cells Product and Solutions
Table 23. ApoCell Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Qiagen (Adnagen) Corporate Information, Location and Competitors
Table 25. Qiagen (Adnagen) Circulating Tumor Cells Major Business
Table 26. Qiagen (Adnagen) Circulating Tumor Cells Total Revenue (USD Million) (2017-2018)
Table 27. Qiagen (Adnagen) SWOT Analysis
Table 28. Qiagen (Adnagen) Circulating Tumor Cells Product and Solutions
Table 29. Qiagen (Adnagen) Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Cynvenio Corporate Information, Location and Competitors
Table 31. Cynvenio Circulating Tumor Cells Major Business
Table 32. Cynvenio Circulating Tumor Cells Total Revenue (USD Million) (2017-2018)
Table 33. Cynvenio SWOT Analysis
Table 34. Cynvenio Circulating Tumor Cells Product and Solutions
Table 35. Cynvenio Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Advanced Cell Diagnostics Corporate Information, Location and Competitors
Table 37. Advanced Cell Diagnostics Circulating Tumor Cells Major Business
Table 38. Advanced Cell Diagnostics Circulating Tumor Cells Total Revenue (USD Million) (2017-2018)
Table 39. Advanced Cell Diagnostics SWOT Analysis
Table 40. Advanced Cell Diagnostics Circulating Tumor Cells Product and Solutions
Table 41. Advanced Cell Diagnostics Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Ikonisys Corporate Information, Location and Competitors
Table 43. Ikonisys Circulating Tumor Cells Major Business
Table 44. Ikonisys Circulating Tumor Cells Total Revenue (USD Million) (2017-2018)
Table 45. Ikonisys SWOT Analysis
Table 46. Ikonisys Circulating Tumor Cells Product and Solutions
Table 47. Ikonisys Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Greiner Bio-one GmbH Corporate Information, Location and Competitors
Table 49. Greiner Bio-one GmbH Circulating Tumor Cells Major Business
Table 50. Greiner Bio-one GmbH Circulating Tumor Cells Total Revenue (USD Million) (2017-2018)
Table 51. Greiner Bio-one GmbH SWOT Analysis
Table 52. Greiner Bio-one GmbH Circulating Tumor Cells Product and Solutions
Table 53. Greiner Bio-one GmbH Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Epic Sciences Corporate Information, Location and Competitors
Table 55. Epic Sciences Circulating Tumor Cells Major Business
Table 56. Epic Sciences Circulating Tumor Cells Total Revenue (USD Million) (2017-2018)
Table 57. Epic Sciences SWOT Analysis
Table 58. Epic Sciences Circulating Tumor Cells Product and Solutions
Table 59. Epic Sciences Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Fluxion Biosciences Corporate Information, Location and Competitors
Table 61. Fluxion Biosciences Circulating Tumor Cells Major Business
Table 62. Fluxion Biosciences Circulating Tumor Cells Total Revenue (USD Million) (2017-2018)
Table 63. Fluxion Biosciences SWOT Analysis
Table 64. Fluxion Biosciences Circulating Tumor Cells Product and Solutions
Table 65. Fluxion Biosciences Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Celsee Corporate Information, Location and Competitors
Table 67. Celsee Circulating Tumor Cells Major Business
Table 68. Celsee Circulating Tumor Cells Total Revenue (USD Million) (2017-2018)
Table 69. Celsee SWOT Analysis
Table 70. Celsee Circulating Tumor Cells Product and Solutions
Table 71. Celsee Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Hangzhou Watson Biotech Corporate Information, Location and Competitors
Table 73. Hangzhou Watson Biotech Circulating Tumor Cells Major Business
Table 74. Hangzhou Watson Biotech Circulating Tumor Cells Total Revenue (USD Million) (2017-2018)
Table 75. Hangzhou Watson Biotech SWOT Analysis
Table 76. Hangzhou Watson Biotech Circulating Tumor Cells Product and Solutions
Table 77. Hangzhou Watson Biotech Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. Clearbridge Biomedics Corporate Information, Location and Competitors
Table 79. Clearbridge Biomedics Circulating Tumor Cells Major Business
Table 80. Clearbridge Biomedics Circulating Tumor Cells Total Revenue (USD Million) (2017-2018)
Table 81. Clearbridge Biomedics SWOT Analysis
Table 82. Clearbridge Biomedics Circulating Tumor Cells Product and Solutions
Table 83. Clearbridge Biomedics Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 84. Guangzhou Wondfo Biotech Corporate Information, Location and Competitors
Table 85. Guangzhou Wondfo Biotech Circulating Tumor Cells Major Business
Table 86. Guangzhou Wondfo Biotech Circulating Tumor Cells Total Revenue (USD Million) (2017-2018)
Table 87. Guangzhou Wondfo Biotech SWOT Analysis
Table 88. Guangzhou Wondfo Biotech Circulating Tumor Cells Product and Solutions
Table 89. Guangzhou Wondfo Biotech Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 90. Biocept Corporate Information, Location and Competitors
Table 91. Biocept Circulating Tumor Cells Major Business
Table 92. Biocept Circulating Tumor Cells Total Revenue (USD Million) (2017-2018)
Table 93. Biocept SWOT Analysis
Table 94. Biocept Circulating Tumor Cells Product and Solutions
Table 95. Biocept Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 96. ANGLE plc Corporate Information, Location and Competitors
Table 97. ANGLE plc Circulating Tumor Cells Major Business
Table 98. ANGLE plc Circulating Tumor Cells Total Revenue (USD Million) (2017-2018)
Table 99. ANGLE plc SWOT Analysis
Table 100. ANGLE plc Circulating Tumor Cells Product and Solutions
Table 101. ANGLE plc Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 102. CytoTrack Corporate Information, Location and Competitors
Table 103. CytoTrack Circulating Tumor Cells Major Business
Table 104. CytoTrack Circulating Tumor Cells Total Revenue (USD Million) (2017-2018)
Table 105. CytoTrack SWOT Analysis
Table 106. CytoTrack Circulating Tumor Cells Product and Solutions
Table 107. CytoTrack Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 108. Global Circulating Tumor Cells Revenue (Million USD) by Players (2015-2020)
Table 109. Global Circulating Tumor Cells Revenue Share by Players (2015-2020)
Table 110. Global Circulating Tumor Cells Revenue (Million USD) by Regions (2015-2020)
Table 111. Global Circulating Tumor Cells Revenue Market Share by Regions (2015-2020)
Table 112. North America Circulating Tumor Cells Revenue by Countries (2015-2020)
Table 113. North America Circulating Tumor Cells Revenue Market Share by Countries (2015-2020)
Table 114. Europe Circulating Tumor Cells Revenue (Million USD) by Countries (2015-2020)
Table 115. Asia-Pacific Circulating Tumor Cells Revenue (Million USD) by Countries (2015-2020)
Table 116. South America Circulating Tumor Cells Revenue by Countries (2015-2020)
Table 117. South America Circulating Tumor Cells Revenue Market Share by Countries (2015-2020)
Table 118. Middle East and Africa Circulating Tumor Cells Revenue (Million USD) by Countries (2015-2020)
Table 119. Middle East and Africa Circulating Tumor Cells Revenue Market Share by Countries (2015-2020)
Table 120. Global Circulating Tumor Cells Revenue (Million USD) by Type (2015-2020)
Table 121. Global Circulating Tumor Cells Revenue Share by Type (2015-2020)
Table 122. Global Circulating Tumor Cells Revenue Forecast by Type (2021-2025)
Table 123. Global Circulating Tumor Cells Revenue by Application (2015-2020)
Table 124. Global Circulating Tumor Cells Revenue Share by Application (2015-2020)
Table 125. Global Circulating Tumor Cells Revenue Forecast by Application (2021-2025)
Table 126. Global Circulating Tumor Cells Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Circulating Tumor Cells Picture
Figure 2. Global Circulating Tumor Cells Revenue Market Share by Type in 2019
Figure 3. CTC Enrichment Picture
Figure 4. CTC Detection Picture
Figure 5. CTC Analysis Picture
Figure 6. Circulating Tumor Cells Revenue Market Share by Application in 2019
Figure 7. Breast Cancer Picture
Figure 8. Prostate Cancer Picture
Figure 9. Colorectal Cancer Picture
Figure 10. Lung Cancer Picture
Figure 11. Other Picture
Figure 12. Global Circulating Tumor Cells Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Circulating Tumor Cells Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Circulating Tumor Cells Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Circulating Tumor Cells Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Circulating Tumor Cells Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Circulating Tumor Cells Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Circulating Tumor Cells Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Circulating Tumor Cells Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Circulating Tumor Cells Revenue Market Share in 2019
Figure 21. Global Top 10 Players Circulating Tumor Cells Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Circulating Tumor Cells Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Circulating Tumor Cells Revenue Market Share by Regions (2015-2020)
Figure 25. Global Circulating Tumor Cells Revenue Market Share by Regions in 2018
Figure 26. North America Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
Figure 27. Europe Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
Figure 29. South America Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
Figure 31. North America Circulating Tumor Cells Revenue Market Share by Countries (2015-2020)
Figure 32. North America Circulating Tumor Cells Revenue Market Share by Countries in 2019
Figure 33. USA Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
Figure 34. Canada Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
Figure 36. Europe Circulating Tumor Cells Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Circulating Tumor Cells Revenue Market Share by Countries in 2019
Figure 38. Germany Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
Figure 39. UK Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
Figure 40. France Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
Figure 41. Russia Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
Figure 42. Italy Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Circulating Tumor Cells Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Circulating Tumor Cells Revenue Market Share by Countries in 2019
Figure 45. China Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
Figure 46. Japan Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
Figure 47. Korea Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
Figure 48. India Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
Figure 50. South America Circulating Tumor Cells Revenue Market Share by Countries (2015-2020)
Figure 51. South America Circulating Tumor Cells Revenue Market Share by Countries in 2019
Figure 52. Brazil Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Circulating Tumor Cells Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Circulating Tumor Cells Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
Figure 57. UAE Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
Figure 60. Global Circulating Tumor Cells Revenue Share by Type (2015-2020)
Figure 61. Global Circulating Tumor Cells Revenue Share by Type in 2019
Figure 62. Global Circulating Tumor Cells Market Share Forecast by Type (2021-2025)
Figure 63. Global CTC Enrichment Revenue Growth Rate (2015-2020)
Figure 64. Global CTC Detection Revenue Growth Rate (2015-2020)
Figure 65. Global CTC Analysis Revenue Growth Rate (2015-2020)
Figure 66. Global Circulating Tumor Cells Revenue Share by Application (2015-2020)
Figure 67. Global Circulating Tumor Cells Revenue Share by Application in 2019
Figure 68. Global Circulating Tumor Cells Market Share Forecast by Application (2021-2025)
Figure 69. Global Breast Cancer Revenue Growth Rate (2015-2020)
Figure 70. Global Prostate Cancer Revenue Growth Rate (2015-2020)
Figure 71. Global Colorectal Cancer Revenue Growth Rate (2015-2020)
Figure 72. Global Lung Cancer Revenue Growth Rate (2015-2020)
Figure 73. Global Other Revenue Growth Rate (2015-2020)
Figure 74. Global Circulating Tumor Cells Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Circulating Tumor Cells Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Circulating Tumor Cells Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Circulating Tumor Cells Revenue Market Forecast (2021-2025)
Figure 78. Europe Circulating Tumor Cells Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Circulating Tumor Cells Revenue Market Forecast (2021-2025)
Figure 80. South America Circulating Tumor Cells Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Circulating Tumor Cells Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
循環腫瘍細胞（CTC）検出器の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Circulating Tumor Cell (CTC) Detector market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value cha…- 循環腫瘍細胞（CTC）診断の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Circulating Tumor Cell (CTC) Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Circ…
- 循環バイオマーカーの世界市場 2020年：企業別・地域別・種類別・用途別市場予測 Market Overview The global Circulating Biomarker market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Circulating Biomarker m…
- 腫瘍切除装置・付属品の世界市場 2020年：企業別・地域別・種類別・用途別市場予測 Market Overview The global Tumor Ablation Equipment and Accessories market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tumo…
- 循環流動層燃焼ボイラー（CFBCボイラー）の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Circulating Fluidized Bed Combustion Boiler (CFBC Boiler) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million …